Abstract
Background
Nicardipine and labetalol are two commonly used antihypertensives for treating elevated blood pressures in the setting of intracerebral hemorrhage (ICH) and subarachnoid hemorrhage (SAH). There are no studies comparing these two agents as continuous infusions.
Methods
A retrospective chart review was conducted of patients admitted between November 2009 and January 2011 with ICH and SAH to compare effectiveness and safety between both agents. Percent time spent at goal was set as the primary outcome. The secondary outcomes included blood pressure variability, time to goal, incidence of bradycardia, tachycardia, and hypotension.
Results
A total of 81 patients were available for analysis, 10 initiated on labetalol (LAB), 57 on nicardipine (NIC), and 14 required the combination of these agents (COMB) to reach goal. We found no difference between NIC, LAB, and the COMB groups in the median percent time at goal [88 % (61–98); 93 % (51–99); 66 % (25–95), (p = NS)]. Median percentage of blood pressure variability, hypotension, and bradycardia were also comparable between groups, however, more tachycardia was observed in the COMB group versus both LAB and NIC groups (45 vs. 0 vs. 3 %; p < 0.001). Mean time to goal SBP in 24 patients who had BP readings available at 1st h of initiation was 32 ± 34 min in the NIC group and 53 ± 42 min in the LAB group (p = 0.03).
Conclusions
Both agents appear equally effective and safe for blood pressure control in SAH and ICH during the initial admission hours. A prospective study is needed to validate these findings.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Shah QA, Ezzeddine MA, Qureshi AI. Acute hypertension in intracerebral hemorrhage: pathophysiology and treatment. J Neurol Sci. 2007;261:74–9.
Bederson JB, Connoly S Jr, Batjer H, et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage. Stroke. 2009;40:994–1025.
Morgenstern LB, Hemphill JC III, Anderson C, et al. Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2010;41:2108–29.
Mayer SA, Kurtz P, Wyman A, et al. Clinical practices, complications, and mortality in neurological patients with acute severe hypertension: studying the treatment of acute hypertension registry. Crit Care Med. 2011;39(10):2330–6.
Malesker MA, Hilleman DE. Intravenous labetalol compared with intravenous nicardipine in the management of hypertension in critically ill patients. J Crit Care. 2012 (in press).
Elastrous S, Nouira S, Besbes LO, et al. Short-term treatment of severe hypertension of pregnancy: prospective comparison of nicardipine and labetalol. Intensive Care Med. 2002;28:1281–6.
Peacock WF, Varon J, Baumann BB, et al. CLUE: a randomized comparative effectiveness trial of IV nicardipine versus labetalol use in the emergency department. Crit Care. 2011;15:R157.
Liu-DeRyke X, Janisse J, Coplin WM, Parker D Jr, Norris G, Rhoney DH. A comparison of nicardipine and labetalol for acute hypertension management following stroke. Neurocrit Care. 2008;9:167–76.
Kross RA, Ferri E, Leung D, et al. A comparative study between a calcium channel blocker (nicardipine) and a combined α-β-blocker (labetalol) for the control of emergence hypertension during craniotomy for tumor surgery. Anesth Analg. 2000;91:904–9.
Woloszyn AV, McAllen KJ, Figueroa BE, DeShane RS, Barletta JF. Retrospective evaluation of nicardipine versus labetalol for blood pressure control in aneurysmal subarachnoid hemorrhage. Neurocrit Care. 2012;16(3):376–80.
Kothari RU, Brott T, Broderick JP, et al. The ABCs of measuring intracerebral hemorrhage volumes. Stroke. 1996;27:1304–5.
Anderson CS, Huang Y, Wang JG, et al. Intensive blood pressure reduction in acute cerebral haemorrhage trial (INTERACT): a randomized pilot trial. Lancet Neurol. 2008;7:391–9.
Antihypertensive treatment of acute cerebral hemorrhage (ATACH) investigators. Antihypertensive treatment of acute cerebral hemorrhage. Crit Care Med. 2010;38:637–48.
Graffagnino C, Bergese S, Love J, et al. Clevidipine rapidly and safely reduces blood pressure in patients with acute intracerebral hemorrhage: interim results of the ACCELERATE trial—first clinical experience in ICH. Neurocrit Care. 2009;11:S7.
Adams HP, del Zoppo G, Alberts MJ, et al. Guidelines for the early management of patients with ischemic stroke. Stroke. 2007;38:1655–711.
Sansing LH, Messe SR, Cucchiara BL, Lyden PD, Kasner SE. Anti-adrenergic medication and edema development after intracerebral hemorrhage. Neurocrit Care. 2011;14:395–400.
Author information
Authors and Affiliations
Corresponding author
Additional information
Santiago Ortega-Gutierrez and Jiz Thomas contributed equally to this study.
Rights and permissions
About this article
Cite this article
Ortega-Gutierrez, S., Thomas, J., Reccius, A. et al. Effectiveness and Safety of Nicardipine and Labetalol Infusion for Blood Pressure Management in Patients with Intracerebral and Subarachnoid Hemorrhage. Neurocrit Care 18, 13–19 (2013). https://doi.org/10.1007/s12028-012-9782-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12028-012-9782-1